Dysfunctional insulin secretion in type 2 diabetes: Role of metabolic abnormalities

Cellular and Molecular Life Sciences

Volumn 57, Issue 3, 2000, Pages 429-440

  Grill, V ^a   Bjorklund A ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Fatty acids; Hyperglycemia; Insulin secretion; Islets of Langerhans; Type 2 diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIAZOXIDE; FATTY ACID; GLUCOSE; INSULIN; PROINSULIN; SOMATOSTATIN;

CELL MEMBRANE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN METABOLISM; INSULIN RELEASE; LANGERHANS CELL; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; REGULATORY MECHANISM; REVIEW;

EID: 0033999680     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000705     Document Type: Review

References (110)

1. 1 Hamman R. (1992) Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab. Rev 8: 287-338
2. 2 Kahn S. (1996) Regulation of beta-cell function in vivo. From health to disease. Diabetes Rev. 4: 372-389
3. 3 Taylor S., Accili D. and Inje Y. (1994) Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes 43: 735-740
4. 4 Kosaka K., Kuzuya T., Akanuma Y. and Hagura R. (1980) Increase in insulin response after treatment of overt maturity-onset diabetes independent of the mode of treatment. Diabetologia 18: 23-28
5. 5 Garvey W., Olefsky J., Griffin J., Hamman R. and Kolterman O. (1985) The effect of insulin treatment on insulin secretion and insulin action in type 2 diabetes mellitus. Diabetes 34: 222-234
6. 6 Ilkova H., Glaser B., Tunckale A., Bagriacik N. and Cerasi E. (1997) Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient insulin treatment. Diabetes Care 20: 1356-1356
7. 7 Matschinsky F. and Sweet I. (1996) Annotated questions and answers about glucose metabolism and insulin secretion of beta cells. Diabetes Rev 4: 130-144
8. 8 Liang Y. and Matschinsky F. (1994) Mechanisms of action of nonglucose insulin secretagogues. Ann. Review Nutrit. 14: 59-81
9. 9 Lang J. (1999) Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur. J. Biochem. 259: 3-17
10. 10 Ashcroft F. and Gribble F. (1999) ATP sensitive K + channels and insulin secretion: their role in health and disease. Diabetologia 42: 203-920
11. 11 Maasen J. and Kadowaki T. (1996) Maternally inherited diabetes and deafness: a new diabetic subtype. Diabetologia 39: 375-382
12. 12 Hayakawa T., Noda M., Yasuda K., Yorifuji H., Taniguchi S., Miwa I. et al. (1998) Ethidium bromide-induced inhibition of mitochondrial gene transcription suppresses glucose-stimulated insulin release in the mouse pancreatic beta-cell line betaHC9. J. Biol. Chem. 273: 20300-20307
13. 13 Eto K., Tsubamoto Y., Terauchi Y., Sugiyama T., Kishimoto T., Takahashi N. et al. (1999) Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 283: 981-985
14. + channels in mouse B-cells. J. Clin. Invest. 89: 1288-1295
15. 15 Miki T., Nagashima K., Tashiro F., Kotake K., Yoshitomi H., Tamamoto A. et al. (1998) Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc. Natl. Acad. Sci. USA 95: 10404-10406
16. 16 Sato Y. and Henquin J.-C. (1998) The K + -ATP channel-independent pathway of regulation of insulin secretion by glucose: in search of the underlying mechanism. Diabetes 47: 1713-1722
17. 17 Maechler P., Kennedy E., Pozzan T. and Wollheim C. (1997) Mitochondrial activation directly triggers the exocytosis of insulin in permeabilized pancreatic beta cells. EMBO J. 16: 3833-3841
18. 2 + -induced exocytosis in mouse pancreatic beta-cells. J. Physiol. 503: 399-412
19. 19 Grodsky G. (1994) An update on implications of phasic insulin secretion. In: Frontiers of Insulin Secretion and Pancreatic Beta-Cell Research, pp. 421-430, Flatt P. and Lenzen S. (eds), Smith-Gordon, London
20. 20 Nauck M. A. (1998) Glucagon-like peptide I (GLP-I): a potent gut hormone with a possible therapeutic perspective. Acta Diabetol. 35: 117-129
21. th edn, pp. 175-197, Rifkin H. and Porte D. Jr (eds), Elsevier, New York
22. 22 Zawalich W. (1996) Regulation of insulin secretion by phosphinositide-specific phospholipase C and protein kinase C activation. Diabetes Rev. 4: 160-176
23. 23 Morgan N., Chan S., Lacey R. and Brown C. (1994) Pharmacology and molecular biology of islet adrenoeeptors In: Frontiers of Insulin Secretion and Pancreatic B-cell Research, pp. 359-368, Flatt P. and Lenzen S. (eds), Smith-Gordon, London
24. 24 Howell S. (1997) The biosynthesis and secretion of insulin. In: Textbook of Diabetes, vol. 1, pp. 8.1-8.14, Pickup J. and Williams G. (eds), Blackwell Science London
25. 25 Dumonteil E. and Philippe J. (1996) Insulin gene: organization, expression and regulation. Diabetes and Metabolism 22: 164-173
26. 26 Edlund H. (1998) Transcribing pancreas. Diabetes 47: 1817-1823
27. 27 Bonner-Weir S. and Smith F. (1994) Islet cell growth and the growth factors involved. Trends Endocrinol. Metabol. 5: 60-64
28. 28 Bouwens L. and Klöppel G. (1996) Islet cell neogenesis in the pancreas. Virshow Arch 427: 553-560
29. 29 Scaglia L., Smith F. and Bonner-Weir S. (1995) Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas. Endocrinology 136: 5461-5468
30. 30 Porte D. (1991) Beta cells in type 2 diabetes mellitus. Diabetes 40: 166-180
31. 31 UK Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS-33). Lancet 352: 837-853
32. 32 Clausson P., Linnarsson R., Sundqvist G., Gottsäter A. and Grill V. (1994) Relationships between diabetes duration, metabolic control and B-cell function in a representative population of type 2 diabetic patients in Sweden. Diabetic Medicine 11: 794-801
33. 33 Kahn S., Andrikopoulos S. and Verchere C. (1999) Islet amyloid. A long-recognized but under-appreciated pathological feature of type 2 diabetes. Diabetes 48: 241-253
34. 34 Hattersley A. (1998) Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabetic Medicine 15: 15-24
35. 35 Hales C. and Barker D. (1992) Type 2 (non-insulin dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35: 595-601
36. 36 Poulsen P., Vaag A., Möller Jensen D. and Beck-Nielsen H. (1997) Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia 40: 439-446
37. 37 Carlsson S., Persson P.-G., Alvarsson A., Efendic S., Norman A., Svanström L. et al. (1999) Low birth weight, family history of diabetes and glucose intolerance in Swedish middle-aged men. Diabetes Care 22: 1043-1047
38. 38 Cook J., Levy J., Page R., Shaw J., Hattersley A. and Turner R. (1993) Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects. Br. Med. J. 306: 302-3066
39. 39 Phillips D., Barker D., Hales C., Hirst S. and Osmond C. (1994) Thinness at birth and insulin resistance in adult life. Diabetologia 37: 150-154
40. 40 Clausen J., Borch-Johnsen K. and Pedersen O. (1997) Relationship between birth weight and the insulin sensitivity index in a population sample of 3311 young healthy Caucasians. Am. J. Epidemiol. 146: 23-31
41. 41 Martin A., Simpsin J. and Freinkel N. (1985) Frequency of diabetes mellitus in probands with gestational diabetes: possible maternal influence on the predisposition to maternal diabetes. Am. J. Obstet. Gynecol. 151: 471-473
42. 42 Pettitt D., Aleck K., Belre R., Carraher M., Bennett P. and Knowler W. (1988) Congenital suceptibility to NIDDM: role of intrauterine environment. Diabetes 37: 622-628
43. 43 Bihoreau M., Ktorza A., Kinebayan M. and Pican L. (1986) Impaired glucose homestasis in adult rats from hyper-glycemic mothers. Diabetes 35: 979-984
44. 44 Aerts L., Sodoyez-Goffaux F., Sodoyez J., Malaisse W. and van Assche F. (1988) The diabetic intrauterine milieu has a long-lasting effect on insulin secretion by B-cells and on insulin uptake in target tissues. Am. J. Obstet. Gynecol. 159: 1287-1292
45. 45 Suzuki N., Aizawa T., Asanuma N., Sato Y., Komatsu M., Hidaka H. et al. (1997) An early intervention accelerates pancreatic beta-cell dysfunction in young Goto-Kakizaki rats, a model of naturally occurring non-insulin dependent diabetes. Endocrinology 138: 1106-1110
46. 46 Movassat J., Saulnier C. and Portha B. (1997) Insulin administration enhances growth of the beta cell mass in streptozotocin-treated newborn rat. Diabetes 46: 1445-1452
47. 47 Everhart J., Pettitt J., Bennett P. and Knowler W. (1992) Duration of obesity increases the incidence of NIDDM. Diabetes 41: 235-240
48. 48 Carlsson S., Persson P.-G., Grill V., Alvarsson M., Efendic S., Norman A. et al. (1998) Weight history, glucose intolerance and insulin levels in Swedish middle-aged men. Am. J. Epidemiol. 148: 539-545
49. 49 Leahy J., Cooper H., Deal D. and Weir G. (1986) Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. J. Clin. Invest. 77: 908-915
50. 50 N'Guyen J.-M., Magnan C., Laury M.-C., Thibault C., Leveteau J., Penicaud L. et al. (1994) Involvement of the autonomic nervous system in the in vivo memory to glucose of pancreatic beta-cell in rats. J. Clin. Invest. 94: 1456-1462
51. 51 Sako Y. and Grill V. (1990) Coupling of B-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats. Diabetes 39: 1580-1583
52. 52 Björklund A. and Grill V. (1993) B-cell insensitivity in vitro: reversal by diazoxide entails more than one event in stimulus-secretion coupling. Endocrinology 132: 1319-1328
53. 53 Bolaffi J., Heldt A., Lewis L. and Grodsky G. (1986) The third phase of in vitro insulin secretion. Evidence for glucose insensitivity. Diabetes 35: 370-373
54. 54 Leahy J. (1996) Beta-cell dysfunction with chronic hyper-glycemia: 'overworked betacell' hypothesis. Diabetes Rev. 4: 298-319
55. 55 Atwater I., Goncalues A., Herchuelz A., Jebran P., Malaisse W., Rojas E. et al. (1984) Cooling dissociates glucose-induced insulin release from electrical activity and cation fluxes in rodent pancreatic islets. J. Physiol. 348: 615-627
56. 56 Renström E., Eliason L., Bokvist K. and Rorsman P. (1996) Cooling inhibits exocytosis in single mouse pancreatic B-cells by suppression of granule mobilization. J. Physiol. 494: 41-52
57. 2O of glucose-induced cyclic AMP accumulation in rat islets of Langerhans. FEBS Lett. 68: 165-169
58. 58 Björklund A. and Grill V. (1999) Association but not linkage of impaired insulin-and Ca2 + responses to glucose in human pancreatic islets. Diabetologia 42 (Suppl 1): A137 (abstract)
59. 59 Marshak S., Leibowitz G., Bertuzzi F., Socci C., Kaiser N., Gross D. et al. (1999) Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 48: 1230-1237
60. 60 Eizirik D., Korbutt G. and Hellerström C. (1992) Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J. Clin. Invest. 90: 1263-1268
61. 61 Björklund A. and Grill V. (1999) Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets. Diabetes 48: 1409-1415
62. 62 Bertuzzi F., Saccomanno K., Socci C., Davalli A., Taglietti M., Berra C. et al. (1998) Long-term in vitro exposure to high glucose increases proinsulin-like molecules released by isolated human islets. J. Endocrinol. 158: 205-211
63. 63 Hostens K., Ling Z., van Schravendijk C. and Pipeleers D. (1999) Prolonged exposure of human beta cells to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine. J. Clin. Endocrinol. Metabol. 84: 1386-1390
64. 64 Leahy J. (1993) Increased proinsulin/insulin ratio in pancreas extracts of hyperglycemic rats. Diabetes 42: 22-27
65. 65 Hostens K., Pavlovic D., Zambre Y., Ling Z., Van Schravendijk C., Eizirik D. et al. (1999) Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release. J. Clin. Invest. 104: 67-72
66. 66 Hiramatsu S. and Grill V. Treatment with diazoxide causes prolonged improvement of B-cell functions of rat islets transplanted to a diabetic environment. Metabolism, in press
67. 67 Efanova I., Zaitsev S. V., Zhivotovsky B., Köhlen M., Efendic S., Orrenius S. et al. (1998) Glucose and tolbutamide induce apoptosis in pancreatic β-cells. J. Biol. Chem 273: 33501-33507
68. 68 McConkey D. and Orrenius S. (1997) The role of calcium in the regulation of apoptosis. Biochem. Biophys. Res. Commun. 239: 357-366
69. 69 DCCT Study (1998) Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. Annals Int. Med. 128: 517-523
70. 70 Björk E., Berne C., Kämpe O., Wibell L., Oskarsson P. and Karlsson F. A. (1996) Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmunne diabetes. Diabetes 45: 1427-1430
71. 71 DCCT Study (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329: 977-986
72. 72 Brownlee M. (1994) Glycation and diabetic complications. Diabetes 43: 836-841
73. 73 Tajiri Y., Möller C. and Grill V. (1997) Long term effects of aminoguanidine on insulin release and biosynthesis. Evidence that the formation of advanced glycosylation end products inhibits B-cell function. Endocrinology 138: 273-280
74. 74 Matsuoka T., Kajimoto Y., Watada H., Kaneto H., Kishimoto M., Umayahara Y. et al. (1997) Glycation-dependent reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Invest. 99: 144-150
75. 75 Cook L., Davies J., Yates A., Elliott A., Lovell J., Joule J. et al. (1998) Effects of methylglyoxal on rat pancreatic beta-cells. Biochem. Pharmacol. 55: 1361-1367
76. 76 Tanaka Y., Gleason C., Tran P., Harmon J. and Robertson P. (1999) Prevention of glucose toxicity in HIR-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc. Natl. Acad. Sci. USA 96: 10857-10862
77. 77 Tajiri Y. and Grill V. (1999) Interactions between vitamin E and glucose on B-cell functions in the rat: an in vivo and in vitro study. Pancreas 18: 274-281
78. 78 Crespin S., Greenough W. and Steinberg D. (1969) Stimulation of insulin secretion by infusion of free fatty acids. J. Clin. Invest. 48: 1934-1943
79. 79 Malaisse W. J. and Malaisse-Lagae F. (1968) Stimulation of insulin secretion by non-carbohydrate metabolites. J. Lab. Clin. Med. 72: 438-448
80. 80 Sako Y. and Grill V. (1990) A 48 h lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B-cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127: 1580-1589
81. 81 Wolf H. (1992) Possible new therapeutic approach in diabetes mellitus by inhibition of carnithine palmitoyl transferase 1 (CPT1). Horm. Metabol. Res. Suppl. 26: 62-67
82. 82 Zhou Y.-P. and Grill V. (1994) Long term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93: 870-876
83. 83 Randle P. J., Priestman D., Mistry S. and Halsall A. (1994) Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia 37(Suppl. 2): S155-S161
84. 84 Zhou Y.-P. and Grill V. (1995) Palmitale-induced B-cell insensitivity to glucose is coupled to decreased pyruvate dehydrogenase activity and enhanced kinase activity in rat pancreatic islets. Diabetes 44: 394-399
85. 85 Priestman D., Mistry A., Halsall A. and Randle P. (1994) Role of protein synthesis and of fatty acid metabolism in the longer term regulation of pyruvate dehydrogenase kinase. Biochem. J. 300: 659-664
86. 86 Liu Y., Tornheim K. and Leahy J. (1999) Glucose-fatty acid cycle to inhibit glucose utilization and oxidation is not operative in fatty acid-cultured islets. Diabetes 48: 1747-1753
87. 87 Segall L., Lameloise N., Assimacopoulos-Jeannet F., Roche E., Corkey P., Thumelin S. et al. (1999) Lipid rather than glucose metabolism is implicated in altered insulin secretion caused by oleate in INS-1 cells. Am. J. Physiol. 277: E521-E528
88. 88 Liang Y., Buetteger C., Berner D. and Matschinsky F. (1997) Chronic effects of fatty acids on insulin release is not through the alteration of glucose metabolism in a pancreatic B-cell line (BHC9). Diabetologia 40: 1018-1027
89. 89 Carlsson C., Borg L. and Welsh N. (1999) Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology 140: 3422-3428
90. 90 Lee Y., Hiroshi H., Ohneda M., Johnson J., McGarry D. and Unger R. (1994) Beta cell lipotoxicity in the pathogenesis of non-insulin dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc. Natl. Acad. Sci. USA 91: 10878-10882
91. 91 Zhou Y.-P., Ling Z.-C. and Grill V. (1996) Inhibitory effects of fatty acids on glucose-regulated B-cell function: association with increased islet triglyceride stores and altered effect of fatty acid oxidation on glucose metabolism. Metabolism 8: 981-986
92. 92 Grupping A., Cnop M., Van Schravendijk C., Hannaert J.-C., Van Berkel T. and Pipeleers D. (1997) Low density lipoprotein binding and uptake by human and rat islet B-cells. Endocrinology 138: 4064-4068
93. 93 Shimabukuro M., Zhou Y.-T., Levi M. and Unger R. (1998) Fatty acid-induced apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. USA 95: 2498-3202
94. 94 Iida M., Murakami T., Ishida K., Mizuno A., Kuwajiima M. and Shima K. (1996) Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker fatty (fa/fa) rat. Biochim. Biophys. Res. Commun. 222: 19-26
95. 95 Shimabukuro M., Koyama K., Chen G., Wang M.-Y., Trieu F., Lee Y. et al. (1997) Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. 94: 4637-4641
96. 96 Zhou Y.-P. and Grill V. (1995) Long-term exposure to fatty acids and kelones inhibits B-cell functions in human pancreatic islets of Langerhans. J. Clin. Endocrinol. Metabol. 80: 1584-1590
97. 97 Bollheimer C., Skelly R., Chester M., McGarry D. and Rhodes C. (1998) Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increased basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J. Clin. Invest. 101: 1094-1101
98. 98 Furukawa H., Carroll R., Swift H. and Steiner D. (1999) Long term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta cell line MIN6. Diabetes 48: 1395-1401
99. 99 Mason T., Goh T., Tchipasvili V., Sandhu H., Gupta N., Lewis G. et al. (1999) Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 48: 524-530
100. 100 Magnan C., Collins S., Berthault M.-F., Kassis N., Vincent M., Gilbert M. et al. (1999) Lipid infusion lowers sympathetic nervous activity and leads to increased beta-cell responsiveness to glucose. J. Clin. Invest. 102: 413-419
101. 101 Paolisso G., Gambardella A., Amato L., Tortoriello R., D'Amore A., Varricchio M. and D'Onofrio F. (1995) Opposite effects of short and long term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38: 1295-1299
102. 102 Boden G., Chen X., Rosner J. and Barton M. (1995) Effects of a 48-fat infusion on insulin secretion and glucose utilization. Diabetes 44: 1239-1242
103. 103 Carpentier A., Mittelman S., Lamarche B., Bergman R., Giacca A. and Lewis G. (1999) Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am. J. Physiol. 276: E1055-E1066
104. 104 Billaudel B. and Suttter B. (1979) Direct effect of corticosterone upon insulin secretion studied by three different techniques. Horm. Metabol. Res. 11: 555-560
105. 105 Lambilotte C., Gilon P. and Henquin J.-C. (1997) Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J. Clin. Invest. 99: 414-423
106. 106 Berglund O., Frankel B. and Hellman B. (1978) Development of the insulin secretory defect in genetically (db/db) mouse. Acta Endocrinol. 87: 543-551
107. 107 Zhou Y.-P., Berggren P.-O. and Grill V. (1996) A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of B-cell dysfunction in the obese diabetic db/db mouse. Diabetes 45: 580-586
108. 108 Capito K., Hansen S., Hedeskov C. and Thams P. (1992) Fat-induced changes in mouse pancreatic islet secretion, insulin biosynthesis and glucose metabolism. Acta Diabetol. 28: 193-198
109. 109 Carpentier A., Lamarche B., Giacca A. and Lewis G. (1998) Difference in the effect of prolonged FFA elevation on glucose-stimulated insulin secretion (GSIS) between non-diabetic subjects and patients with type 2 diabetes. Diabetes 47 (Suppl. 1): A255 (abstract)
110. 110 Qvigstad E., Mostad I., Bjerve K. and Grill V. (1999) Acute reduction of fatty acids increases insulin secretion in type 2 diabetes. Diabetologia 42 (Suppl. 1): A153 (abstract)